FDA Announces New Recommendations for Acceptable Limits of Nitrosamine in Drugs
The FDA has released new guidance on acceptable intake limits for certain nitrosamines and how drug manufacturers should test for them.
Tag Archives: NDMA
-
-
Zantac Trial Scheduled To Begin in November Before California State Court Jury
A Zantac cancer lawsuit filed in California will go before a jury in November, however no specific case has yet been selected, according to a Reuters report.
-
GSK Settles Zantac Bladder Cancer Lawsuit Ahead of California State Court Trial
A Zantac bladder cancer lawsuit scheduled to go to trial next month in California has been resolved through a confidential settlement agreement, GlaxoSmithKline says.
-
California Zantac Lawsuit Over Cancer Risks Cleared By State Court Judge to Proceed on Strength of Plaintiff’s Expert Witnesses
A California judge will allow Zantac lawsuits to move forward after allowing plaintiffs' expert witnesses to testify.
-
FDA Questioned About Plans To Investigate GSK For Hiding Cancer Risk from Zantac
A House lawmaker is asking FDA whether it plans to investigate GlaxoSmithKline for potentially hiding cancer risks from Zantac for decades in order to maintain profits.
-
Potential Risk of Cancer from Zantac Known By Drug Maker For Decades: Report
An investigative report indicates GlaxoSmithKline knew Zantac could transform into NDMA, a known cancer-causing chemical, since the drug was first developed, but never told the FDA.
-
Court Consolidates 40 Zantac Lawsuits Pending in New York State for Pretrial Litigation
Dozens of Zantac lawsuits filed in New York state courts have been consolidated for pretrial proceedings over claims the recalled heartburn drug may cause cancer.
-
Chantix Recall Lawsuits Over Cancer Risk Consolidated in Southern District of New York
All Chantix recall cancer lawsuits are to be consolidated in a southern New York federal court for pretrial proceedings.
-
Zantac Lawsuit Filed By Dozens of Plaintiffs in Delaware State Court After Federal MDL Dismissed
Despite dismissal of federal Zantac lawsuits, plaintiffs continue to file claims in state courts.
-
Valsartan NDMA Lawsuits Cleared To Move Forward, After Motion for Reconsideration Rejected
A federal judge has cleared Valsartan NDMA lawsuits to proceed after rejecting a call by defendants to reconsider the admissibility of plaintiffs' expert witnesses following the recent dismissal of Zantac…
